V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300003303 | 300002302 | 1.74 | null | Curative (C) | 2014-05-31 | 2014-06-05 | CISPLATIN + FLUOROURACIL | 02 | N | 300015181 | CISPLATIN + FLUOROURACIL |
| 300003304 | 300002303 | 1.73 | 83.2 | null | 2016-07-14 | 2016-07-15 | Trial Unspecified | Y | N | 300015183 | TRIAL |
| 300003305 | 300002304 | 1.53 | 66.5 | Adjuvant (A) | 2017-01-30 | 2017-02-16 | Trial Unspecified | 02 | null | 300015186 | TRIAL |
| 300003306 | 300002305 | 1.63 | 102 | null | 2017-04-16 | 2017-05-24 | CETUXIMAB | N | Y | 300015192 | CETUXIMAB |
| 300003310 | 300002307 | 1.44 | 94.8 | null | 2013-12-11 | 2013-12-12 | Capecitabine | N | N | 300015198 | CAPECITABINE |
| 300003311 | 300005911 | 1.67 | 62.6 | Curative (C) | 2016-09-09 | 2016-09-19 | CISPLATIN + FLUOROURACIL | 02 | N | 300015203 | CISPLATIN + FLUOROURACIL |
| 300003312 | 300002308 | 1.69 | 54.4 | Palliative (P) | 2013-10-04 | 2013-10-04 | Carboplatin + Paclitaxel (3 weekly) | N | N | 300015204 | CARBOPLATIN + PACLITAXEL |
| 300003313 | 300002309 | 1.52 | 66 | Adjuvant (A) | 2015-01-23 | 2015-02-19 | CETUXIMAB + RT | N | Y | 300015206 | CETUXIMAB + RT |
| 300003314 | 300002310 | null | null | Curative (C) | null | 2014-09-20 | Capecitabine | N | N | 300015207 | CAPECITABINE |
| 300003315 | 300002311 | 1.58 | null | Not known (9) | null | 2017-11-02 | CETUXIMAB + RT | null | Y | 300015209 | CETUXIMAB + RT |
| 300003316 | 300002311 | 1.52 | 96.4 | Neo-adjuvant (N) | 2017-03-05 | 2017-03-18 | CISPLATIN + FLUOROURACIL | 02 | null | 300015209 | CISPLATIN + FLUOROURACIL |
| 300003317 | 300002312 | null | 100.6 | Adjuvant (A) | 2015-11-17 | 2015-12-16 | Capecitabine | 02 | N | 300015211 | CAPECITABINE |
| 300003318 | 300002312 | null | 87.8 | Neo-adjuvant (N) | 2014-03-18 | 2014-04-07 | CISPLATIN + FLUOROURACIL | N | N | 300015211 | CISPLATIN + FLUOROURACIL |
| 300003319 | 300002313 | 1.7 | 78.1 | Neo-adjuvant (N) | 2014-11-02 | 2014-11-08 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 300015219 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003320 | 300002314 | 1.74 | 95.5 | Curative (C) | 2013-03-05 | 2013-03-24 | CETUXIMAB + RT | 01 | Y | 300015225 | CETUXIMAB + RT |
| 300003321 | 300002315 | 1.66 | 96 | Curative (C) | 2016-09-27 | 2016-09-30 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 300015230 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003322 | 300002316 | null | null | Neo-adjuvant (N) | 2013-09-29 | 2013-10-25 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 300015236 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003323 | 300002317 | null | 74.3 | Neo-adjuvant (N) | null | 2014-07-25 | Cisplatin +Fluorouracil (3 wk) | null | null | 300015249 | CISPLATIN + FLUOROURACIL |
| 300003324 | 300002318 | 1.71 | 65 | Adjuvant (A) | 2014-04-01 | 2014-04-01 | CETUXIMAB + RT | N | N | 300015251 | CETUXIMAB + RT |
| 300003325 | 300002319 | null | 95.5 | Adjuvant (A) | 2016-01-29 | 2016-01-30 | Capecitabine | 02 | N | 300015255 | CAPECITABINE |
| 300003327 | 300002321 | 1.6 | 55 | Palliative (P) | 2015-08-03 | 2015-08-22 | Cisplatin +Fluorouracil (3 wk) | N | N | 300015264 | CISPLATIN + FLUOROURACIL |
| 300003328 | 300002321 | 1.61 | 77.8 | Curative (C) | 2013-12-09 | 2013-12-14 | Cisplatin +Fluorouracil (2 wk) | 2 | N | 300015264 | CISPLATIN + FLUOROURACIL |
| 300003329 | 300002322 | 1.54 | 88 | null | 2013-05-21 | 2013-05-28 | CISPLATIN + FLUOROURACIL | N | N | 300015273 | CISPLATIN + FLUOROURACIL |
| 300003330 | 300002323 | 1.6 | 95.8 | Curative (C) | 2013-05-27 | 2013-06-11 | CETUXIMAB | N | N | 300015275 | CETUXIMAB |
| 300003331 | 300002323 | 1.52 | 62.8 | null | 2014-06-12 | 2014-06-27 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 300015275 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003332 | 300002324 | 1.75 | 88 | Curative (C) | 2015-09-28 | 2015-09-28 | Cisplatin +Fluorouracil (3 wk) | N | N | 300015280 | CISPLATIN + FLUOROURACIL |
| 300003333 | 300002325 | 1.66 | null | Neo-adjuvant (N) | 2013-11-30 | 2013-12-16 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300015282 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003334 | 300002326 | 1.76 | 66.35 | Neo-adjuvant (N) | 2016-08-01 | 2016-08-15 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300015285 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003335 | 300002327 | 1.55 | null | Palliative (P) | 2016-01-16 | 2016-01-16 | CISPLATIN + FLUOROURACIL | 02 | N | 300015287 | CISPLATIN + FLUOROURACIL |
| 300003336 | 300002328 | null | 86.7 | null | 2016-08-19 | 2016-08-22 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300015288 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003337 | 300002329 | 1.71 | 77.2 | null | 2016-03-12 | 2016-04-04 | CISPLATIN + FLUOROURACIL | Y | null | 300015289 | CISPLATIN + FLUOROURACIL |
| 300003338 | 300002330 | 1.78 | 92 | Curative (C) | 2014-09-23 | 2014-09-26 | Trial Unspecified | 2 | N | 300015292 | TRIAL |
| 300003339 | 300002331 | 1.73 | 75 | Curative (C) | 2013-06-11 | 2013-06-17 | Cetuximab + Radiotherapy Maint | Y | Y | 300015293 | CETUXIMAB + RT |
| 300003341 | 300005916 | 1.73 | 118.2 | Palliative (P) | 2017-08-25 | 2017-09-09 | Capecitabine | null | N | 300015296 | CAPECITABINE |
| 300003342 | 300005916 | 1.79 | null | Curative (C) | 2013-03-05 | 2013-03-12 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 300015296 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003343 | 300002333 | 1.55 | 77.2 | Palliative (P) | 2017-12-20 | 2018-01-17 | Capecitabine | N | N | 300015303 | CAPECITABINE |
| 300003344 | 300002334 | 1.68 | 56.9 | Curative (C) | 2014-12-03 | 2014-12-18 | CETUXIMAB + RT | N | Y | 300015310 | CETUXIMAB + RT |
| 300003345 | 300002335 | 1.6 | 60 | Curative (C) | 2013-09-26 | 2013-09-28 | Cetuximab 7 day (Cycle 1) | 02 | N | 300015317 | CETUXIMAB |
| 300003346 | 300002335 | null | 82.9 | Curative (C) | 2015-04-22 | 2015-05-18 | Capecitabine | 02 | N | 300015317 | CAPECITABINE |
| 300003347 | 300002335 | 1.6 | 156 | Curative (C) | 2014-08-04 | 2014-08-04 | CETUXIMAB + RT | Y | Y | 300015317 | CETUXIMAB + RT |
| 300003348 | 300007952 | 1.77 | 63.2 | Curative (C) | 2016-08-18 | 2016-08-28 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300015346 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003349 | 300002336 | 1.86 | 68.1 | Neo-adjuvant (N) | null | 2013-07-07 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300015347 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003350 | 300002337 | 1.61 | 85.5 | Adjuvant (A) | null | 2013-07-26 | Capecitabine | N | N | 300015350 | CAPECITABINE |
| 300003351 | 300002337 | 1.62 | 78.1 | Palliative (P) | 2016-10-26 | 2016-11-03 | Capecitabine | 02 | N | 300015350 | CAPECITABINE |
| 300003352 | 300002337 | 1.6 | 108 | Neo-adjuvant (N) | 2014-12-30 | 2015-01-03 | CISPLATIN + DOCETAXEL + FLUOROURACIL | Y | N | 300015350 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003353 | 300002337 | 1.55 | 74.2 | Palliative (P) | 2016-04-27 | 2016-05-20 | CETUXIMAB | N | Y | 300015350 | CETUXIMAB |
| 300003354 | 300008201 | 1.79 | 67.5 | Neo-adjuvant (N) | 2016-04-06 | 2016-04-21 | Cisplatin +Fluorouracil (3 wk) | N | N | 300015356 | CISPLATIN + FLUOROURACIL |
| 300003355 | 300008308 | 1.43 | 57.2 | Neo-adjuvant (N) | 2014-08-31 | 2016-08-08 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300015357 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003356 | 300002338 | 1.59 | 77.9 | null | 2013-08-28 | 2013-09-15 | Cetuximab + Radiotherapy Load | 02 | Y | 300015363 | CETUXIMAB + RT |
| 300003357 | 300002339 | 1.83 | 60.9 | Not known (9) | 2017-09-17 | 2017-09-30 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300015369 | CISPLATIN + DOCETAXEL + FLUOROURACIL |